Inrig Jula sold TVTX
July 1, 2025 · Form 4 insider transaction
Inrig Jula sold 815 shares of Travere Therapeutics, Inc. at $14.65 per share, a transaction worth $11.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
815
Price
$14.65
Total value
$11.9K
InsiderInrig Jula
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 1, 2025
Filing dateJuly 2, 2025
Shares owned after88,787
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of additional shares to cover the tax obligation that occurred upon the vesting of performance-based restricted stock units (PSUs) that vested in February 2025.